These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36830706)

  • 1. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Kieneker LM; la Bastide-van Gemert S; Gordijn SJ; Hidden C; Nilsen T; Gansevoort RT; Mulder DJ; Dullaart RPF; de Borst MH; Bakker SJL; van Goor H
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Campo S; Fazio MR; Nicocia G; Buemi M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
    Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case-control study in a regional hospital in Ghana.
    Danquah M; Owiredu WKBA; Jnr BAE; Serwaa D; Odame Anto E; Peprah MO; Obirikorang C; Fondjo LA
    BMC Nephrol; 2023 Apr; 24(1):114. PubMed ID: 37101162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
    Hasegawa M; Ishii J; Kitagawa F; Takahashi K; Hayashi H; Koide S; Tomita M; Takahashi H; Ozaki Y; Yuzawa Y
    Heart Vessels; 2015 Jan; 30(1):81-8. PubMed ID: 24378882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C
    Crit Care; 2014 Feb; 18(1):R39. PubMed ID: 24581340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.